Nathan Radcliffe, MD
Enriched profileAssociate Professor of Ophthalmology, Icahn School of Medicine at Mount Sinai · Icahn School of Medicine at Mount Sinai
Nathan Radcliffe is Associate Professor of Ophthalmology, Icahn School of Medicine at Mount Sinai at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 177 publications with 2,726 citations (h-index 28); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Nathan Radcliffe, MD, is Associate Professor of Ophthalmology, Icahn School of Medicine at Mount Sinai. The public record shows 177 publications with 2,726 citations (h-index 28), centered on Glaucoma. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 45 companies.
- Most recent indexed publication: 2025 · Clinical ophthalmology (Auckland, N.Z.)
- Top research focus: Glaucoma
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 45 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Direct Selective Laser Trabeculoplasty (DSLT) for Patients With Glaucoma or Ocular Hypertension Previously Treated With SLT
Sponsor: The New York Eye Surgery Center
- Clarifying the Optimal Application of SLT Therapy Trial
Sponsor: University of Pittsburgh
- Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
Sponsor: The New York Eye Surgery Center
Industry payments
Updated 31 Aug 2026
45 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Beaver-Visitec International, Inc.Program year20252 payments$85,208openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year2025106 payments$77,261openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year202553 payments$73,075openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
84%Prostaglandin Analog36.2%Latanoprost79%Lumigan18%Iyuzeh2%Travoprost1%Part D<11 patientsCarbonic Anhydrase Inhibitor21.8%Dorzolamide-Timolol65%Simbrinza11%Acetazolamide Er9%Dorzolamide Hcl9%Brinzolamide4%Acetazolamide2%Part D≥504 patientsCancer & immunology
4.5%Calcineurin inhibitor4.5%Restasis91%Cyclosporine7%Vevye2%Part D<11 patientsCardiovascular
4.3%Beta blocker4.3%Timolol Maleate90%Betaxolol Hcl10%Part D≥145 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 31 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRIS(®) Registry (Intelligent Research in Sight).
Clinical ophthalmology (Auckland, N.Z.)
Article2025 - Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements.
Clinical ophthalmology (Auckland, N.Z.)
Article2023 - Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature.
Clinical ophthalmology (Auckland, N.Z.)
Review2023 - Factors associated with vision loss in Black or Hispanic patients 1 year after standalone or combined Ahmed glaucoma valve surgery.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Article2022 - Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection.
Clinical ophthalmology (Auckland, N.Z.)
Article2022
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nathan-radcliffe-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
drradcliffe.com
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →drradcliffe.com ↗ - X / Twitter
x.com/n8radcliffe
Mentions by others
where others cite or feature them- Instagram
instagram.com/glaucomatoday/p/C33DcAKtEjB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
eyetube.net/podcasts/gt-the-podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyetube.net ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Temple University School of Medicine (Lewis Katz School of Medicine), graduated Alpha Omega Alpha
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗ - Transitional Residency
University of Hawaii
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyoph.com ↗ - Ophthalmology Residency (Chief Resident)
New York University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗ - Glaucoma Fellowship (Chief Fellow)
New York Eye and Ear Infirmary
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗ - Board Certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyoph.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyeworld.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗
- Top 40 Ophthalmologist Under 40
The Ophthalmologist journal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗ - Transitional Resident of the Year
University of Hawaii
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →drradcliffe.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →drradcliffe.com ↗
- New York Eye Surgery Center
Bronx, NY
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyeye.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyoph.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomatoday.com ↗
- Podcast guest
'Management of Advanced Glaucoma' with Blake Williamson MD and Gary Wortz MD
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eyesoneyecare.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai